幹細胞バンク市場規模、シェア、成長分析、供給源別、サービスタイプ別、用途別、地域別 - 産業予測、2024年～2031年

幹細胞バンクの世界市場規模は2022年に91億米ドルと評価され、2023年の98億5,000万米ドルから2031年には186億5,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは18.30%で成長する見通しです。

世界の幹細胞バンク市場は、凍結保存と細胞バンク調製プロセスの進歩によって急成長を遂げています。モノクローナル抗体や効率的なバイオ医薬品の人気に後押しされ、幹細胞治療の採用が増加していることが、市場の需要を大きく高めています。幹細胞を用いた治療、特に造血移植の継続的な研究開発は、神経変性疾患や心血管疾患の治療に有望な機会を提供しています。組織バンクやバイオバンクは、多様な臨床応用のために成体組織や幹細胞を保存する上で極めて重要な役割を果たしており、また極低温凍結はそれらの長期的な生存性を保証しています。以前は治療不可能だった疾患に対するIPS細胞のような再生医療の開拓は、市場をさらに押し上げます。さらに、晩婚化の動向は、生物学的保険の一形態として臍帯血バンクへの関心を高めており、市場の成長を大きく後押ししています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制情勢
• ケーススタディ分析
• 技術分析
• サプライチェーン分析
• バリューチェーン分析
• PESTEL分析

幹細胞バンク市場：供給源別

• 市場概要
• 胎盤幹細胞（PSCS）
• 脂肪組織由来幹細胞（ADSCS）
• 骨髄由来幹細胞（BMSCS）
• ヒト胚由来幹細胞（HESCS）
• 歯髄由来幹細胞（DPSCS）
• その他の供給源

幹細胞バンク市場：サービスタイプ別

• 市場概要
• サンプルの保存と保管
• サンプル分析
• サンプル処理
• サンプルの収集と輸送

幹細胞バンク市場：用途別

• 市場概要
• 個別化されたバンク用途
• 調査用途
  • 疾患治療研究
  • ライフサイエンス調査
  • 創薬
• 臨床応用
  • 造血障害
  • 自己免疫疾患
  • その他の病気

幹細胞バンク市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Cordlife（Singapore）
• Cryo-Cell International（US）
• LifeCell International（India）
• StemCyte（US）
• Global Cord Blood（Hong Kong）
• Smart Cells International（UK）
• Vita34（Germany）
• CryoHoldco（US）
• Cellerant Therapeutics, Inc.（US）
• StemCell Technologies Inc.（Canada）
• Regenexx（US）
• Athersys, Inc.（US）
• Mesoblast Limited（Australia）
• Cytori Therapeutics, Inc.（US）
• OrthoGenics（US）
• Panthera Biopartners（UK）
• Stemson Therapeutics（US）
• Lonza Group AG（Switzerland）
• Macopharma（France）
• Cure Cell（Turkey）
• LifeBankUSA（US）
• Biolife Plasma Services, LLC（US）
• NexImmune, Inc.（US）

Global Stem Cell Banking Market size was valued at USD 9.1 billion in 2022 and is poised to grow from USD 9.85 billion in 2023 to USD 18.65 billion by 2031, growing at a CAGR of 18.30% during the forecast period (2024-2031).

The global stem cell banking market is witnessing rapid growth driven by advancements in cryopreservation and cell bank preparation processes. The rising adoption of stem cell therapy, fueled by the popularity of monoclonal antibodies and efficient biopharmaceuticals, is significantly enhancing market demand. Continuous R&D in stem cell-based therapies, particularly for hematopoietic transplantation, offers promising opportunities for treating neurodegenerative and cardiovascular diseases. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells for diverse clinical applications, while cryogenic freezing ensures their long-term viability. The development of regenerative medicine, such as IPS cells for previously untreatable conditions, further boosts the market. Additionally, the trend of late parenthood has heightened interest in umbilical cord blood banking as a form of biological insurance, significantly driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Banking Market Segmental Analysis

Global Stem Cell Banking Market is segmented by Source, Service Type, Application, and region. Based on Source, the market is segmented into Placental Stem Cells (PSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS), and Other Stem Cell Sources. Based on Service Type, the market is segmented into Sample Preservation and Storage, Sample Analysis, Sample Processing, and Sample Collection and Transportation. Based on Application, the market is segmented into Personalized Banking Applications, Research Applications, and Clinical Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Stem Cell Banking Market

Our analysis reveals that the global stem cell banking market is experiencing a significant shift toward the use of adult stem cells, particularly those derived from bone marrow or adipose tissue. These stem cells are gaining traction due to their ethical acceptability and ease of accessibility compared to embryonic stem cells. Additionally, advancements in minimally invasive collection techniques, such as needle-based bone marrow extraction, are enhancing patient convenience and reducing discomfort. This progress is driving increased adoption and awareness of stem cell banking, as it provides a reliable and patient-friendly option for preserving valuable biological resources. Consequently, these developments are propelling the growth and popularity of the stem cell banking market worldwide.

Restraints in the Global Stem Cell Banking Market

The global stem cell banking market faces a significant restraint in the form of ever-evolving regulatory frameworks. Governments worldwide are enforcing stringent guidelines to ensure safety and uphold ethical standards in stem cell research and banking. However, navigating these intricate and frequently changing regulatory landscapes presents a considerable challenge for market players. The continuous evolution or unpredictability of regulations often disrupts operations and hinders market growth. Companies must invest substantial resources to stay compliant, adapting their practices to align with new requirements, which can strain financial and operational capacities. This regulatory uncertainty not only adds complexity but also discourages potential investments and innovation in the sector, thereby acting as a barrier to the market's overall expansion.

Market Trends of the Global Stem Cell Banking Market

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is driving the demand for innovative treatment solutions globally. Stem cell therapies are emerging as a promising approach to treat and potentially cure these chronic illnesses, showcasing transformative potential in healthcare. As a result, there is a rising need for readily available stem cell sources, which is fueling the growth of stem cell banking services. By providing a reliable repository for stem cells, these banks are positioned to support advancements in regenerative medicine and personalized treatments, catering to the evolving needs of the healthcare industry. This trend underscores the critical role of stem cell banking in shaping the future of disease management and therapeutic innovation.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Case Study Analysis
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• PESTEL Analysis

Stem Cell Banking Market by Source

• Market Overview
• Placental Stem Cells (PSCS)
• Adipose Tissue-Derived Stem Cells (ADSCS)
• Bone Marrow-Derived Stem Cells (BMSCS)
• Human Embryo-Derived Stem Cells (HESCS)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Other Stem Cell Sources

Stem Cell Banking Market by Service Type

• Market Overview
• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection and Transportation

Stem Cell Banking Market by Application

• Market Overview
• Personalized Banking Applications
• Research Applications
  • Disease Treatment Studies
  • Life Science Research
  • Drug Discovery
• Clinical Applications
  • Hematopoietic Disorders
  • Autoimmune Disorders
  • Other Diseases

Stem Cell Banking Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Cordlife (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell International (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Cord Blood (Hong Kong)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Cells International (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vita34 (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoHoldco (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellerant Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regenexx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoGenics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panthera Biopartners (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemson Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cure Cell (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeBankUSA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolife Plasma Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments